Covid, UK ໄຟສີຂຽວສໍາລັບຢາວັກຊີນ Moderna bivalent ທີ່ຍັງຕ້ານ Omicron

Bivalent vaccine against Covid: the country is the first to approve Moderna’s drug which tackles both the original Wuhan strain and the first variant of Omicron and will be part of the autumn booster campaign

The UK is the first country to approve Moderna’s new bivalent vaccine

The vaccine addresses both the original strain of Covid-19 (the one that emerged in Wuhan in 2019) and the first variant of Omicron (BA.1).

The vaccine will now be part of the autumn booster campaign.

Moderna will try to make 13 million doses of the new vaccine available, but 26 million people could benefit from a booster dose.

Experiments on 437 people showed that the updated, bivalent vaccine is safe and offers better immune protection against the new variants

“Levels of antibodies capable of attaching to and disabling Omicron (BA.1) were 1.7 times higher in people given the new vaccine.

Tests against the newer variants of Omicron (BA.4 and BA.5), which caused the latest wave of infections in the UK, also showed higher levels of protection with the updated vaccine,’ reads the BBC.

WHO WILL GET THE FOURTH DOSE IN THE AUTUMN

The UK’s Joint Committee on Vaccination and Immunisation (Jcvi) has confirmed that some form of booster should be offered in the autumn to the following groups of people: health and social care staff; the over-50s; carers over the age of 16; frail people over the age of five, including pregnant women; and people over the age of five who share a household with someone with a weakened immune system.

Moderna, the BBC reports, is not the only company upgrading its vaccines.

Pfizer has also developed vaccines that can target Omicron.

The Oxford-AstraZeneca vaccine, on the other hand, is not being updated.

ອ່ານຍັງ:

ມີຊີວິດສຸກເສີນຫຼາຍຂຶ້ນ…ສົດ: ດາວໂຫລດແອັບຟຣີໃໝ່ຂອງໜັງສືພິມຂອງເຈົ້າສຳລັບ IOS ແລະ Android

Covid, ວິທີການຮັບຮູ້ອາການຂອງ Centaurus? ລະວັງດັງດັງ ແລະ ໄອແຫ້ງ

ປະເທດເອທິໂອເປຍຈະສັກຢາປ້ອງກັນພະຍາດອະຫິວາ 2 ລ້ານຄົນໃນພາກພື້ນ Tigray

ໃນປະເທດ Chad ຫຼາຍກວ່າ 3.3 ລ້ານເດັກນ້ອຍໄດ້ຮັບການສັກຢາປ້ອງກັນໃນຂະບວນການໂປລີໂອຂະ ໜາດ ໃຫຍ່

Malawi, Polio ກັບຄືນມາ: WHO ປະກາດ

Monkeypox ການລະບາດ: ສິ່ງທີ່ຄວນຮູ້

Monkeypox, 202 ກໍ​ລະ​ນີ​ໃຫມ່​ລາຍ​ງານ​ໃນ​ເອີ​ຣົບ​: ວິ​ທີ​ການ​ມັນ​ໄດ້​ຮັບ​ການ​ຕິດ​ຕໍ່​

ອາການຂອງ Monkeypox ແມ່ນຫຍັງ?

ໃນປະເທດຊິມບັບເວ 54,407 ຄົນຢູ່ເມືອງ Chegutu ໄດ້ຮັບການສັກຢາປ້ອງກັນອະຫິວາຟຣີ

ມາ​ລາ​ວີ​ໄດ້​ຮັບ​ຢາ​ວັກ​ຊີ​ນ​ອະ​ຫິວ​າ 1.9 ລ້ານ​ໂດ​ສ ເພື່ອ​ເສີມ​ຂະ​ຫຍາຍ​ການ​ກຽມ​ພ້ອມ ແລະ ການ​ຕອບ​ສະ​ໜອງ​ຂອງ​ໂລກ​ອະ​ຫິວາ

ໂຄວິດ-19, ເປັນຊ່ວງເວລາທີ່ມີນ້ຳຕົກສຳລັບຫ້ອງທົດລອງຢາໃນອາຟຣິກາ

ຊຸກຍູ້ການທົດລອງ Monkeypox Laboratory ໃນອາຟຣິກາ

ທີ່​ມາ​:

Agenzia ຮ້າຍ

ນອກນັ້ນທ່ານຍັງອາດຈະຢາກ